Crossmark

Combination of TACE and Lenvatinib as a promising option for downstaging to surgery of initially unresectable intrahepatic cholangiocarcinoma

Published Online: 2022-07-06

Published Print: 2022-10

Authors

Yuan, Peng

Song, Jinhua

Wang, Fei

Zhu, Guangyu

Chen, Baoan https://orcid.org/0000-0001-5903-8749
License Information

Text and Data Mining valid from 2022-07-06

Version of Record valid from 2022-07-06
More Information

Article History

Received: 22 February 2022

Accepted: 12 May 2022

First Online: 6 July 2022

Change Date: 13 December 2022

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s10637-022-01323-6

Conflict of interest

: No conflict of interests was declared in the study.

Updates are available Correction dated 2022-12-13